Back to MNKD Stock Lookup
Pages: 1 2 »» Last Page

MannKind (MNKD) – Corporate News

Jan 21, 2016 09:01 AM MannKind (MNKD) Enters Into Collaboration and License Agreement with Receptor Life Sciences
Jan 11, 2016 09:06 AM MannKind (MNKD) Says DeSisto Won't Be President & CEO; Names Matthew Pfeffer as CEO
Jan 5, 2016 09:03 AM MannKind (MNKD) Announces Termination of Licensing Agreement with Sanofi (SNY); Will Evaluate Options for Afrezza
Jan 5, 2016 09:02 AM MannKind (MNKD) Announces Termination of Its License Agreement With Sanofi (SNY)
Dec 23, 2015 05:31 PM MannKind (MNKD) Names Duane DeSisto as President and CEO
Dec 7, 2015 04:08 PM MannKind (MNKD) Enters Separation Agreement with Former CEO Edstrom
Nov 20, 2015 08:01 AM MannKind (MNKD) CEO Edstrom Steps Down
Nov 12, 2015 02:33 PM MannKind (MNKD) Prices 13.85M Common Offering at ~$2.61/Share
Nov 12, 2015 02:33 PM MannKind (MNKD) Prices Registered Direct Offering at $2.61/Share
Nov 9, 2015 04:28 PM UPDATE: MannKind (MNKD) to Sell Up to 50M Shares in Israel
Oct 26, 2015 09:01 AM MannKind (MNKD) Returns 9M Shares of BofA Under Stock Lending Agreement
Oct 23, 2015 09:10 AM MannKind (MNKD) Approved for Dual Listing on Tel Aviv Stock Exchange
Jul 31, 2015 09:01 AM MannKind (MNKD) Announces Tripling of Afrezza Production
Jul 29, 2015 08:55 AM MannKind (MNKD) Enters Exchange Agreements with Certain Senior Convertible Noteholders
Apr 27, 2015 09:02 AM MannKind (MNKD) Will Begin Manufacturing of 12 Unit Cartridge Strength of AFREZZA
Mar 20, 2015 08:29 AM UPDATE: MannKind (MNKD) Lower on Script Data Concerns
Feb 3, 2015 07:01 AM Sanofi (SNY), MannKind (MNKD) Report Afrezza Now Availabile in U.S.
Jan 12, 2015 07:06 AM MannKind (MNKD) CEO Alfred Mann to Retire; Will Transition to Executive Chairman
Jan 8, 2015 07:06 AM MannKind (MNKD) Earns $50M Milestone from Sanofi
Sep 29, 2014 08:40 AM MannKind (MNKD) Enters Revolving Note, Security Agreement with Aventisub
Sep 24, 2014 05:01 PM MannKind (MNKD), Sanofi (SNY) Close Global Development, Commercialization Agreement for Afrezza
Aug 11, 2014 05:51 AM MannKind (MNKD) Inks Afrezza Licensing Agreement with Sanofi (SNY)
Aug 5, 2014 05:15 PM MannKind (MNKD) and Amphastar Enter Insulin Supply Agreement
Jun 30, 2014 06:20 AM MannKind (MNKD) Affirms FDA Approval of Afrezza
Apr 7, 2014 06:23 AM FDA Extends PDUFA Date for Mannkind's (MNKD) Afrezza
Apr 1, 2014 05:50 PM MannKind (MNKD): FDA Advisory Committee Recommends Approval of AFREZZA(R)
Apr 1, 2014 05:50 PM Mannkind (MNKD) Confirms FDA Panel Backs AFREZZA for Diabetes
Oct 14, 2013 09:25 AM MannKind (MNKD) Stock Higher after Resubmits AFREZZA NDA
Aug 14, 2013 05:12 PM Mannkind (MNKD) Working With Greenhill on Formal Partnering Process
Aug 14, 2013 06:15 AM MannKind (MNKD) AFREZZA Phase 3s Met Primary Endpoints in Type 1 & 2 Diabetes
Aug 14, 2013 06:14 AM MannKind Corp (MNKD) Reports Positive AFREZZA Phase 3 Results in Type 2 Diabetes
Jul 1, 2013 09:04 AM Mannkind (MNKD) Announces $160M Senior Notes Financing
Jun 17, 2013 09:19 AM MannKind (MNKD) Completes P-3 Study of AFREZZA
May 31, 2013 04:08 PM MannKind (MNKD) Completes Follow-Ups of AFREZZA Phase 3
Nov 13, 2012 08:09 AM Mannkind (MNKD) in License Deal with Colby Worth up to $140M
Oct 18, 2012 09:29 AM MannKind (MNKD) Prices 40M Common, 30M Warrants Offering
Oct 5, 2012 06:10 AM Mannkind (MNKD) Completes Patient Recruitment for AFREZZA
Apr 30, 2012 07:13 AM Tolero Pharma, MannKind (MNKD) Enter BTK Licensing Agreement; MannKind to Get $130M Upfront
Feb 3, 2012 06:51 AM MannKind (MNKD) Enters 31.25M Committed Purchase Agreement
Feb 3, 2012 06:50 AM MannKind (MNKD) Prices 31.25M Offering a $2.40/Unit
Sep 23, 2011 07:19 AM MannKind (MNKD) Announces $370M Senior Notes Offering
Aug 12, 2011 06:50 AM MannKind (MNKD) Confirms Two AFREZZA Studies with U.S. FDA
Apr 13, 2011 07:20 AM FDA Delays End-of-Review Meeting with MannKind (MNKD)
Apr 11, 2011 06:59 AM FDA Cancels End-of-Review Meeting with MannKind (MNKD)
Jan 19, 2011 05:45 PM MannKind (MNKD) Plummets 40% After FDA Requests More Trials for Insulin Inhaler
Nov 5, 2010 07:56 AM MannKind Corp. (MNKD) Issues Statement on Recent Lawsuit; "Arditi's Claims Have No Merit"
Oct 19, 2010 01:03 PM MannKind Corp. (MNKD) Initiates Phase 2 of MKC1106-MT
Aug 11, 2010 07:27 AM MannKind Corp. (MNKD) Enters 18.2M Common Purchase Commitment with Seaside 88
Jul 20, 2010 09:18 AM U.S. FDA Accepts MannKind's (MNKD) Submission of NDA for AREZZA, Classifies as Class 2 Resubmission
Jun 29, 2010 06:52 AM MannKind (MNKD) To Present Positive Data for AFREZZA in Patients with Type 2 Diabetes
Pages: 1 2 »» Last Page

Back to MNKD Stock Lookup